SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-087924
Filing Date
2022-08-09
Accepted
2022-08-09 16:25:51
Documents
15
Period of Report
2022-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2222823d1_8k.htm   iXBRL 8-K 33128
2 EXHIBIT 99.1 tm2222823d1_ex99-1.htm EX-99.1 122159
7 GRAPHIC tm2222823d1_ex99-1img01.jpg GRAPHIC 3670
  Complete submission text file 0001104659-22-087924.txt   409723

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vacc-20220809.xsd EX-101.SCH 3556
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vacc-20220809_def.xml EX-101.DEF 28720
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vacc-20220809_lab.xml EX-101.LAB 38347
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vacc-20220809_pre.xml EX-101.PRE 26926
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2222823d1_8k_htm.xml XML 6658
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Vaccitech plc (Filer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 221148726
SIC: 2834 Pharmaceutical Preparations